Chronic DVT ‐ antiplatelet agents plus BMP vs BMP alone
Recurrent VTE ‐ early and intermediate · people requiring treatment for chronic DVT
It is very uncertain whether chronic DVT ‐ antiplatelet agents plus BMP changes recurrent VTE ‐ early and intermediate compared with BMP alone (very low certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of deep venous thrombosis 2022 · Cochrane Headline outcomes onlyRR 0.12 [0.05, 0.34]1 study · 224 participantsVery low